Aquestive Therapeutics (AQST) Preferred Shares (2017)

Aquestive Therapeutics (AQST) recorded quarterly Preferred Shares of $16.9 million in Q4 2017.

Aquestive Therapeutics (AQST) Preferred Shares (2017) Analysis & Trends

Aquestive Therapeutics' Preferred Shares history runs 1 years deep, the most recent figure standing at $16.9 million for Q4 2017.

In Q4 2017, Preferred Shares changed N/A year-over-year to $16.9 million; the TTM figure through Dec 2017 stood at $16.9 million (changed N/A YoY), while the FY2017 annual figure was $16.9 million, changed N/A from the prior year.
Preferred Shares was $16.9 million for Q4 2017 at Aquestive Therapeutics.
In the past five years, Preferred Shares ranged from a high of $16.9 million in Q4 2017 to a low of $16.9 million in Q4 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Aquestive Therapeutics	488.60 Mn	377.87 Mn	10.98 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2017	16.89 Mn